Viewing Study NCT04965818


Ignite Creation Date: 2025-12-25 @ 4:39 AM
Ignite Modification Date: 2025-12-26 @ 3:42 AM
Study NCT ID: NCT04965818
Status: TERMINATED
Last Update Posted: 2024-09-19
First Post: 2021-07-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer
Sponsor: Taiho Oncology, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module